Human platelet lysate gel provides a novel three dimensional-matrix for enhanced culture expansion of mesenchymal stromal cells

Tissue Engineering - Part C: Methods

Volumn 18, Issue 12, 2012, Pages 924-934

  Walenda, Gudrun ^a   Hemeda, Hatim ^a   Schneider, Rebekka K ^b   Merkel, Rudolf ^c   Hoffmann, Bernd ^c   Wagner, Wolfgang ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOGENIC; CELL DENSITY; CHONDROGENIC; COLONY FORMING UNITS; CULTURE MEDIUM; FETAL CALF SERUMS; GOOD MANUFACTURING PRACTICES; IMMUNOPHENOTYPES; IN-VITRO; MESENCHYMAL STROMAL CELLS; NON-ENZYMATIC; OSTEOGENIC; PLASTIC SURFACES; PROLIFERATION RATE; REGENERATIVE MEDICINE; TISSUE CULTURE PLASTICS; WASHING STEPS;

CELLS; FLOWCHARTING; PLATELETS; POLYSACCHARIDES;

CELL CULTURE;

BOVINAE;

ARTICLE; CELL DIVISION; CYTOLOGY; GEL; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; MESENCHYMAL STROMA CELL; METABOLISM; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE;

BLOOD PLATELETS; CELL DIVISION; GELS; HUMANS; IMMUNOPHENOTYPING; MESENCHYMAL STROMAL CELLS; MICROSCOPY, ELECTRON, SCANNING;

EID: 84869064521     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2011.0541     Document Type: Article

References (52)

1. Sensebe, L., Krampera, M., Schrezenmeier, H., Bourin, P., and Giordano, R. Mesenchymal stem cells for clinical application. Vox Sang 98, 93, 2009.
2. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D., and Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8, 315, 2006.
3. Neuss, S., Apel, C., Buttler, P., Denecke, B., Dhanasingh, A., Ding, X., Grafahrend, D., Groger, A., Hemmrich, K., Herr, A., Jahnen-Dechent, W., Mastitskaya, S., Perez-Bouza, A., Rosewick, S., Salber, J., Woltje, M., and Zenke, M. Assessment of stem cell/biomaterial combinations for stem cellbased tissue engineering. Biomaterials 29, 302, 2008.
4. Cholewa, D., Stiehl, T., Schellenberg, A., Bokermann, G., Joussen S, Koch C,Walenda T, Pallua, N.,Marciniak-Czochra, A., Suschek, C.V., and Wagner W. Expansion of adipose mesenchymal stromal cells is affected by human platelet lysate and plating density. Cell Transplant 20, 1409, 2011.
5. Toh, W.S., Lim, T.C., Kurisawa, M., and Spector, M. Modulation of mesenchymal stem cell chondrogenesis in a tunable hyaluronic acid hydrogel microenvironment. Biomaterials 33, 3835, 2012.
6. Zhang, J., Skardal, A., and Prestwich, G.D. Engineered extracellular matrices with cleavable crosslinkers for cell expansion and easy cell recovery. Biomaterials 29, 4521, 2008.
7. Leisten I., Kramann S., Ventura Ferreira M.S., Ziegler P., Wagner W., Neuss S., Knü chel R., and Schneider R. Threedimensional co-culture of hematopoietic stem and progenitor cells and mesenchymal stem cells in collagen scaffolds: an in vitro model of the hematopoetic niche. Biomaterials 33, 1736, 2012.
8. Wagner, W., Roderburg, C., Wein, F., Diehlmann, A., Frankhauser, M., Schubert, R., Eckstein, V., and Ho, A.D. Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors. Stem Cells 10, 2638, 2007.
9. Wagner, W., Feldmann, R.E., Jr., Seckinger, A., Maurer, M.H., Wein, F., Blake, J., Krause, U., Kalenka, A., Burgers, H.F., Saffrich, R., Wuchter, P., Kuschinsky, W., and Ho, A.D. The heterogeneity of human mesenchymal stem cell preparations-Evidence from simultaneous analysis of proteomes and transcriptomes. Exp Hematol 34, 536, 2006.
10. Eagle, H. Nutrition needs of mammalian cells in tissue culture. Science 122, 501, 1955.
11. Heiskanen, A., Satomaa, T., Tiitinen, S., Laitinen, A., Mannelin, S., Impola, U., Mikkola, M., Olsson, C., Miller-Podraza, H., Blomqvist, M., Olonen, A., Salo, H., Lehenkari, P., Tuuri, T., Otonkoski, T., Natunen, J., Saarinen, J., and Laine, J. N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells 25, 197, 2007.
12. Sundin, M., Ringden, O., Sundberg, B., Nava, S., Gotherstrom, C., and Le, B.K. No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica 92, 1208, 2007.
13. Schallmoser, K., Bartmann, C., Rohde, E., Reinisch, A., Kashofer, K., Stadelmeyer, E., Drexler, C., Lanzer, G., Linkesch, W., and Strunk, D. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47, 1436, 2007.
14. Bieback, K., Hecker, A., Kocaomer, A., Lannert, H., Schallmoser, K., Strunk, D., and Kluter, H. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 27, 2331, 2009.
15. Carrancio, S., Lopez-Holgado, N., Sanchez-Guijo, F.M., Villaron, E., Barbado, V., Tabera, S., ez-Campelo, M., Blanco, J., San Miguel, J.F., and Del Canizo, M.C. Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Exp Hematol 36, 1014, 2008.
16. Avanzini, M.A., Bernardo, M.E., Cometa, A.M., Perotti, C., Zaffaroni, N., Novara, F., Visai, L., Moretta, A., Del, F.C., Villa, R., Ball, L.M., Fibbe, W.E., Maccario, R., and Locatelli, F. Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood-and bone marrow-derived progenitors. Haematologica 94, 1649, 2009.
17. Doucet, C., Ernou, I., Zhang, Y., Llense, J.R., Begot, L., Holy, X., and Lataillade, J.J. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 205, 228, 2005.
18. Holzwarth, C., Vaegler, M., Gieseke, F., Pfister, S.M., Handgretinger, R., Kerst, G., and Muller, I. Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells. BMC Cell Biol 11, 11, 2010.
19. Muller, I., Kordowich, S., Holzwarth, C., Spano, C., Isensee, G., Staiber, A., Viebahn, S., Gieseke, F., Langer, H., Gawaz, M.P., Horwitz, E.M., Conte, P., Handgretinger, R., and Dominici, M. Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy 8, 437, 2006.
20. Lange, C., Cakiroglu, F., Spiess, A.N., Cappallo-Obermann, H., Dierlamm, J., and Zander, A.R. Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol 213, 18, 2007.
21. Perez-Ilzarbe, M., ez-Campelo, M., Aranda, P., Tabera, S., Lopez, T., del, C.C., Merino, J., Moreno, C., Andreu, E.J., Prosper, F., and Perez-Simon, J.A. Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy. Transfusion 49, 1901, 2009.
22. Horn, P., Bokermann, G., Cholewa, D., Bork, S., Walenda, T., Koch, C., Drescher, W., Hutschenreuther, G., Zenke, M., Ho, A., and Wagner W. Comparison of individual platelet lysates for isolation of human mesenchymal stromal cells. Cytotherapy 12, 888, 2010.
23. Schallmoser K., and Strunk D. Preparation of pooled human platelet lysate (pHPL) as an efficient supplement for animal serum-free human stem cell cultures. J Vis Exp 30, 1523, 2009.
24. Schallmoser, K., Rohde, E., Reinisch, A., Bartmann, C., Thaler, D., Drexler, C., Obenauf, A.C., Lanzer, G., Linkesch, W., and Strunk, D. Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng Part C Methods 14, 185, 2008.
25. Bonin, M., Stolzel, F., Goedecke, A., Richter, K., Wuschek, N., Holig, K., Platzbecker, U., Illmer, T., Schaich, M., Schetelig, J., Kiani, A., Ordemann, R., Ehninger, G., Schmitz, M., and Bornhauser, M. Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant 43, 245, 2009.
26. Lucchini, G., Introna, M., Dander, E., Rovelli, A., Balduzzi, A., Bonanomi, S., Salvade, A., Capelli, C., Belotti, D., Gaipa, G., Perseghin, P., Vinci, P., Lanino, E., Chiusolo, P., Orofino, M.G., Marktel, S., Golay, J., Rambaldi, A., Biondi, A., D'Amico, G., and Biagi, E. Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population. Biol Blood Marrow Transplant 16, 1293, 2010.
27. Harrison, P., and Cramer, E.M. Platelet alpha-granules. Blood Rev 7, 52, 1993.
28. Lohmann, M., Walenda, G., Hemeda, H., Joussen, S., Drescher, W., Jockenhoevel, S., Hutschenreuter, G., Zenke, M., and Wagner, W. Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells. PLoS One 2012.
29. Schneider, R.K., Puellen, A., Kramann, R., Raupach, K., Bornemann, J., Knuechel, R., Perez-Bouza, A., and Neuss, S. The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodelling in three-dimensional collagen scaffolds. Biomaterials 31, 467, 2010.
30. Koroleva, A., Gittard, S., Schlie, S., Deiwick, A., Jockenhoevel, S., and Chichkov, B. Fabrication of fibrin scaffolds with controlled microscale architecture by a two-photon polymerization-micromolding technique. Biofabrication 4, 015001, 2012.
31. Koch, C., Suschek, C.V., Lin, Q., Bork, S., Goergens, M., Joussen, S., Pallua, N., Ho, A.D., Zenke, M., and Wagner, W. Specific age-associated DNA methylation changes in human dermal fibroblasts. PLoS One 6, e16679, 2011.
32. Walenda, T., Bork, S., Horn, P., Wein, F., Saffrich, R., Diehlmann, A., Eckstein, V., Ho, A.D., and Wagner, W. Co-Culture with mesenchymal stromal cells increases proliferation and maintenance of hematopoietic progenitor cells. J Cell Mol Med 14, 337, 2010.
33. Schellenberg, A., Stiehl, T., Horn, P., Joussen, S., Pallua, N., Ho, A., and Wagner W. Population dynamics of mesenchymal stromal cells during culture expansion. Cytotherapy 14, 401, 2012.
34. Wagner, W., Horn, P., Castoldi, M., Diehlmann, A., Bork, S., Saffrich, R., Benes, V., Blake, J., Pfister, S., Eckstein, V., and Ho, A.D. Replicative senescence of mesenchymal stem cells-a continuous and organized process. PLoS One 5, e2213, 2008.
35. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
36. Friedenstein, A.J., Petrakova, K.V., Kurolesova, A.I., and Frolova, G.P. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6, 230, 1968.
37. Copland, I.B., Lord-Dufour, S., Cuerquis, J., Coutu, D.L., Annabi, B., Wang, E., and Galipeau, J. Improved autograft survival of mesenchymal stromal cells by plasminogen activator inhibitor 1 inhibition. Stem Cells 27, 467, 2009.
38. Wagner, W., and Ho, A.D. Mesenchymal stem cell preparations-comparing apples and oranges. Stem Cell Rev 3, 239, 2007.
39. Bensaid, W., Triffitt, J.T., Blanchat, C., Oudina, K., Sedel, L., and Petite, H. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 24, 2497, 2003.
40. Jockenhoevel, S., Zund, G., Hoerstrup, S.P., Chalabi, K., Sachweh, J.S., Demircan, L., Messmer, B.J., and Turina, M. Fibrin gel-advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardiothorac Surg 19, 424, 2001.
41. Shaikh, F.M., Callanan, A., Kavanagh, E.G., Burke, P.E., Grace, P.A., and McGloughlin, T.M. Fibrin: a natural biodegradable scaffold in vascular tissue engineering. Cells Tissues Organs 188, 333, 2008.
42. Lucarelli, E., Beretta, R., Dozza, B., Tazzari, P.L., O'Connel, S.M., Ricci, F., Pierini, M., Squarzoni, S., Pagliaro, P.P., Oprita, E.I., and Donati, D. A recently developed bifacial platelet-rich fibrin matrix. Eur Cell Mater 20, 13, 2010.
43. Koch, S., Flanagan, T.C., Sachweh, J.S., Tanios, F., Schnoering, H., Deichmann, T., Ella, V., Kellomaki, M., Gronloh, N., Gries, T., Tolba, R., Schmitz-Rode, T., and Jockenhoevel, S. Fibrin-polylactide-based tissue-engineered vascular graft in the arterial circulation. Biomaterials 31, 4731, 2010.
44. Dozza, B., Di, B.C., Lucarelli, E., Giavaresi, G., Fini, M., Tazzari, P.L., Giannini, S., and Donati, D. Mesenchymal stem cells and platelet lysate in fibrin or collagen scaffold promote non-cemented hip prosthesis integration. J Orthop Res 29, 961, 2011.
45. Coppinger, J.A., Cagney, G., Toomey, S., Kislinger, T., Belton, O.,McRedmond, J.P., Cahill, D.J., Emili, A., Fitzgerald, D.J., and Maguire, P.B. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 103, 2096, 2004.
46. Kocaoemer, A., Kern, S., Kluter, H., and Bieback, K. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 25, 1270, 2007.
47. Wirz, S., Dietrich, M., Flanagan, T.C., Bokermann, G., Wagner, W., Schmitz-Rode, T., and Jockenhoevel, S. Influence of platelet-derived growth factor-AB on tissue development in autologous platelet-rich plasma gels. Tissue Eng Part A 17, 1891, 2011.
48. Gorodetsky, R., Vexler, A., Shamir, M., An, J., Levdansky, L., Shimeliovich, I., and Marx, G. New cell attachment peptide sequences from conserved epitopes in the carboxy termini of fibrinogen. Exp Cell Res 287, 116, 2003.
49. Weber, C., Pohl, S., Portner, R., Wallrapp, C., Kassem, M., Geigle, P., and Czermak, P. Expansion and Harvesting of hMSC-TERT. Open Biomed Eng J 1, 38, 2007.
50. Takahashi, H., Nakayama, M., Yamato, M., and Okano, T. Controlled chain length and graft density of thermoresponsive polymer brushes for optimizing cell sheet harvest. Biomacromolecules 11, 1991, 2010.
51. Cholewinski, E., Dietrich, M., Flanagan, T.C., Schmitz-Rode, T., and Jockenhoevel, S. Tranexamic acid-an alternative to aprotinin in fibrin-based cardiovascular tissue engineering. Tissue Eng Part A 15, 3645, 2009.
52. Engler, A.J., Sen, S., Sweeney, H.L., and Discher, D.E. Matrix elasticity directs stem cell lineage specification. Cell 126, 677, 2006.